Skip to main content

Advertisement

SpringerLink
Log in

The Autoimmune Side of Heart and Lung Diseases

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

The elevated cardiovascular morbidity in rheumatoid arthritis, systemic lupus erythematosus, and the antiphospholipid syndrome is well known, as well as the pulmonary involvement observed in these conditions and to a major extent in systemic sclerosis. These manifestations constitute a major challenge for clinicians involved in patient management. Moreover, several issues regarding the link between autoimmune rheumatic diseases and cardio pulmonary morbidity remain largely enigmatic. The mechanistic role of certain autoantibodies frequently observed in association with heart and lung diseases or the pathogenetic link between chronic inflammation and the pathways leading to atherosclerosis or pulmonary vascular changes are yet to be elucidated. As such, these questions as well as treatment strategies are of common interest to rheumatologists, immunologist, pulmonologists, and cardiologists and thus call for an interdisciplinary approach. This paradigm has been well established for rare conditions such as the Churg–Strauss syndrome. Nowadays, it seems that this approach should be expanded to encompass more common conditions such as coronary heart disease, pulmonary arterial hypertension or dilated cardiomyopathy. The present issue of Clinical Reviews in Allergy and Immunology addresses the new knowledge and concepts of autoimmune-related cardiopulmonary diseases. The issue derives from the 2010 International Autoimmunity Meeting held in Ljubljana, Slovenia and is thus timely and dedicated to the latest developments in this new multidisciplinary field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bussone G, Mouthon L (2011) Interstitial lung disease in systemic sclerosis. Autoimmun Rev 10:248–255

    Article  PubMed  Google Scholar 

  2. Lee CG, Herzog EL, Ahangari F et al (2012) Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-beta1 signaling. J Immunol 189:2635–2644

    Article  PubMed  CAS  Google Scholar 

  3. McCormick LL, Zhang Y, Tootell E, Gilliam AC (1999) Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 163:5693–5699

    PubMed  CAS  Google Scholar 

  4. Szczeklik W, Jakiela B, Adamek D and Musial J (2011) Cutting edge issues in the Churg–Strauss syndrome. Clin Rev Allergy Immunol. doi:10.1007/s12016-011-8266-y

  5. Bartoloni E, Alunno A, Bistoni O and Gerli R (2011) Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy. Clin Rev Allergy Immunol. doi:10.1007/s12016-010-8251-x

  6. Fousteri G, Dave A, Morin B, Omid S, Croft M, von Herrath MG (2011) Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis. J Autoimmun 36:210–220

    Article  PubMed  CAS  Google Scholar 

  7. Fae KC, da Silva DD, Oshiro SE et al (2006) Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol 176:5662–5670

    PubMed  CAS  Google Scholar 

  8. Fedoseyeva EV, Zhang F, Orr PL, Levin D, Buncke HJ, Benichou G (1999) De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 162:6836–6842

    PubMed  CAS  Google Scholar 

  9. Nussinovitch U and Shoenfeld Y (2011) The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease. Clin Rev Allergy Immunol. doi:10.1007/s12016-010-8229-8

  10. Nussinovitch U and Shoenfeld Y (2010) The Clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease. Clin Rev Allergy Immunol. doi:10.1007/s12016-010-8228-9

  11. Roux-Lombard P, Pagano S, Montecucco F, Satta N and Vuilleumier N (2010) Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases. Clin Rev Allergy Immunol. doi:10.1007/s12016-010-8233-z

  12. Kalache S, Dinavahi R, Pinney S, Mehrotra A, Cunningham MW, Heeger PS (2011) Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients. J Immunol 187:1023–1030

    Article  PubMed  CAS  Google Scholar 

  13. Fu SM, Deshmukh US, Gaskin F (2011) Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR. J Autoimmun 37:104–112

    Article  PubMed  CAS  Google Scholar 

  14. Hickman-Brecks CL, Racz JL, Meyer DM, LaBranche TP, Allen PM (2011) Th17 cells can provide B cell help in autoantibody induced arthritis. J Autoimmun 36:65–75

    Article  PubMed  CAS  Google Scholar 

  15. Karnabi E, Qu Y, Wadgaonkar R et al (2010) Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) L-type Ca channel. J Autoimmun 34:80–86

    Article  PubMed  CAS  Google Scholar 

  16. Lee TP, Tang SJ, Wu MF, Song YC, Yu CL, Sun KH (2010) Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes. J Autoimmun 35:358–367

    Article  PubMed  CAS  Google Scholar 

  17. Somers K, Geusens P, Elewaut D et al (2011) Novel autoantibody markers for early and seronegative rheumatoid arthritis. J Autoimmun 36:33–46

    Article  PubMed  CAS  Google Scholar 

  18. Doria A, Zen M, Canova M et al (2010) SLE diagnosis and treatment: when early is early. Autoimmun Rev 10:55–60

    Article  PubMed  CAS  Google Scholar 

  19. Hernandez-Molina G, Leal-Alegre G, Michel-Peregrina M (2011) The meaning of anti-Ro and anti-La antibodies in primary Sjogren’s syndrome. Autoimmun Rev 10:123–125

    Article  PubMed  CAS  Google Scholar 

  20. Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME (2010) Definition of human autoimmunity–autoantibodies versus autoimmune disease. Autoimmun Rev 9:A259–A266

    Article  PubMed  CAS  Google Scholar 

  21. Cantarini L, Imazio M, Brizi MG et al (2010) Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clin Rev Allergy Immunol. doi:10.1007/s12016-010-8219-x

  22. Kontaki E, Boumpas DT (2010) Innate immunity in systemic lupus erythematosus: sensing endogenous nucleic acids. J Autoimmun 35:206–211

    Article  PubMed  CAS  Google Scholar 

  23. Cantarini L, Imazio M, Brucato A, Lucherini OM, Galeazzi M (2010) Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis. Autoimmun Rev 9:436–440

    Article  PubMed  Google Scholar 

  24. Etzioni A (2010) Contemporary challenges in human innate immunodeficiency syndromes. Clin rev allergy & immunolo 38:1–2

    Article  Google Scholar 

  25. Wollenberg A, Rawer HC, Schauber J (2011) Innate immunity in atopic dermatitis. Clin rev allergy immunol 41:272–281

    Article  PubMed  CAS  Google Scholar 

  26. Varin MM, Le Pottier L, Youinou P, Saulep D, Mackay F, Pers JO (2010) B-cell tolerance breakdown in Sjogren’s syndrome: focus on BAFF. Autoimmun Rev 9:604–608

    Article  PubMed  CAS  Google Scholar 

  27. Benucci M, Manfredi M, Puttini PS, Atzeni F (2010) Predictive factors of response to rituximab therapy in rheumatoid arthritis: what do we know today? Autoimmun Rev 9:801–803

    Article  PubMed  CAS  Google Scholar 

  28. Conti F, Perricone C, Ceccarelli F, Valesini G (2010) Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: two sides of the same coin. Autoimmun Rev 9:716–720

    Article  PubMed  CAS  Google Scholar 

  29. Saraux A (2010) The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjogren’s syndrome. Autoimmun Rev 9:609–614

    Article  PubMed  Google Scholar 

  30. Behrens M, Smart M, Luckey D, Luthra H, Taneja V (2011) To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice. J Autoimmun 37:95–103

    Article  PubMed  CAS  Google Scholar 

  31. Arora-Singh RK, Assassi S, del Junco DJ et al (2010) Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis. J Autoimmun 35:52–57

    Article  PubMed  CAS  Google Scholar 

  32. Xiang Y, Peng J, Tai N et al (2012) The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD mice. J Immunol 188:4747–4758

    Article  PubMed  CAS  Google Scholar 

  33. Ahuja A, Shupe J, Dunn R, Kashgarian M, Kehry MR, Shlomchik MJ (2007) Depletion of B cells in murine lupus: efficacy and resistance. J Immunol 179:3351–3361

    PubMed  CAS  Google Scholar 

  34. Fabris M, Quartuccio L, Lombardi S et al (2012) The CC homozygosis of the -174 G > C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis. Autoimmun Rev 11:315–320

    Article  PubMed  CAS  Google Scholar 

  35. Chin L, Andersen JN, Futreal PA (2011) Cancer genomics: from discovery science to personalized medicine. Nat med 17:297–303

    Article  PubMed  CAS  Google Scholar 

  36. McKinney EF, Lyons PA, Carr EJ et al (2010) A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat med 16:586–591, 581p following 591

    Article  PubMed  CAS  Google Scholar 

  37. Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y (2010) Epigenetics and autoimmunity. J Autoimmun 34:J207–J219

    Article  PubMed  CAS  Google Scholar 

  38. Ballestar E (2010) Epigenetics lessons from twins: prospects for autoimmune disease. Clin rev allergy immunol 39:30–41

    Article  PubMed  CAS  Google Scholar 

  39. Grolleau-Julius A, Ray D, Yung RL (2010) The role of epigenetics in aging and autoimmunity. Clin rev allergy immunol 39:42–50

    Article  PubMed  CAS  Google Scholar 

  40. Renaudineau Y (2010) The revolution of epigenetics in the field of autoimmunity. Clin rev allergy immunol 39:1–2

    Article  PubMed  CAS  Google Scholar 

  41. McClymont SA, Putnam AL, Lee MR et al (2011) Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 186:3918–3926

    Article  PubMed  CAS  Google Scholar 

  42. Lee WW, Yang ZZ, Li G, Weyand CM, Goronzy JJ (2007) Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis. J Immunol 179:2609–2615

    PubMed  CAS  Google Scholar 

  43. Trenkmann M, Brock M, Ospelt C, Gay S (2010) Epigenetics in rheumatoid arthritis. Clin rev allergy immunol 39:10–19

    Article  PubMed  CAS  Google Scholar 

  44. Zhao S, Long H, Lu Q (2010) Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials. Clin rev allergy immunol 39:3–9

    Article  PubMed  Google Scholar 

  45. Selmi C, Leung PS, Sherr DH et al (2012) Mechanisms of environmental influence on human autoimmunity: A National Institute of Environmental Health Sciences Expert Panel workshop. J Autoimmun. doi:10.1016/j.jaut.2012.05.007

  46. Miller FW, Alfredsson L, Costenbader KH et al (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel workshop. J Autoimmun. doi:10.1016/j.jaut.2012.05.002

  47. Germolec D, Kono DH, Pfau JC and Pollard KM (2012) Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop. J Autoimmun. doi:10.1016/j.jaut.2012.05.020

  48. Miller FW, Pollard KM, Parks CG et al (2012) Criteria for environmentally associated autoimmune diseases. J Autoimmun. doi:10.1016/j.jaut.2012.05.001

  49. Sharma R, Fu SM, Ju ST (2011) IL-2: a two-faced master regulator of autoimmunity. J Autoimmun 36:91–97

    Article  PubMed  CAS  Google Scholar 

  50. Baraut J, Michel L, Verrecchia F, Farge D (2010) Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmun Rev 10:65–73

    Article  PubMed  CAS  Google Scholar 

  51. Oo YH, Adams DH (2010) The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun 34:45–54

    Article  PubMed  CAS  Google Scholar 

  52. Tiegs G, Lohse AW (2010) Immune tolerance: what is unique about the liver. J Autoimmun 34:1–6

    Article  PubMed  CAS  Google Scholar 

  53. Novick D, Elbirt D, Miller G, Dinarello CA, Rubinstein M, Sthoeger ZM (2010) High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. J Autoimmun 34:121–126

    Article  PubMed  CAS  Google Scholar 

  54. Scheinecker C, Bonelli M, Smolen JS (2010) Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. J Autoimmun 35:269–275

    Article  PubMed  CAS  Google Scholar 

  55. Zandman-Goddard G, Orbach H, Agmon-Levin N et al (2011) Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients. Clin Rev Allergy Immunol. doi:10.1007/s12016-011-8264-0

  56. Sousa GM, Oliveira RC, Pereira MM, Parana R, Sousa-Atta ML, Atta AM (2011) Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin. Autoimmun Rev 10:210–213

    Article  PubMed  CAS  Google Scholar 

  57. Kherbeck N, Tamby MC, Bussone G et al (2011) The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension. Clin Rev Allergy Immunol. doi:10.1007/s12016-011-8265-z

  58. Yan Y, Wang YH, Diamond B (2012) IL-6 contributes to an immune tolerance checkpoint in post germinal center B cells. J Autoimmun 38:1–9

    Article  PubMed  CAS  Google Scholar 

  59. Aricha R, Mizrachi K, Fuchs S, Souroujon MC (2011) Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis. J Autoimmun 36:135–141

    Article  PubMed  CAS  Google Scholar 

  60. Drucker C, Gewiese J, Malchow S, Scheller J, Rose-John S (2010) Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration. J Autoimmun 34:29–37

    Article  PubMed  CAS  Google Scholar 

  61. Lisi S, Sisto M, Lofrumento DD et al (2010) Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis. J Autoimmun 35:160–170

    Article  PubMed  CAS  Google Scholar 

  62. Hemdan NY, Birkenmeier G, Wichmann G et al (2010) Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev 9:785–792

    Article  PubMed  CAS  Google Scholar 

  63. Chan AL, Rafii R, Louie S and Albertson TE (2011) Therapeutic update in idiopathic pulmonary fibrosis. Clin Rev Allergy Immunol

  64. Borchers AT, Leibushor N, Cheema GS, Naguwa SM, Gershwin ME (2011) Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases. J Autoimmun 37:273–288

    Article  PubMed  CAS  Google Scholar 

  65. Szekanecz Z, Szanto S, Szabo Z et al (2010) Biologics—beyond the joints. Autoimmun Rev 9:820–824

    Article  PubMed  Google Scholar 

  66. Gualtierotti R, Biggioggero M and Meroni PL (2011) Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome. Clin Rev Allergy Immunol. doi:10.1007/s12016-011-8268-9

  67. de la Torre YM, Pregnolato F, D’Amelio F et al (2012) Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the beta2 glycoprotein I phospholipid-binding site. Implications for human fetal loss. J Autoimmun 38:J209–J215

    Article  PubMed  Google Scholar 

  68. Saponjski J, Stojanovich L, Djokovic A, Petkovic M, Mrda D (2011) Systemic vascular diseases in the antiphospholipid syndrome. What is the best diagnostic choice? Autoimmun Rev 10:235–237

    Article  PubMed  Google Scholar 

  69. Cervera R, Balasch J (2010) Autoimmunity and recurrent pregnancy losses. Clin rev allergy immunol 39:148–152

    Article  PubMed  CAS  Google Scholar 

  70. De Carolis S, Botta A, Santucci S et al (2010) Predictors of pregnancy outcome in antiphospholipid syndrome: a review. Clin rev allergy immunol 38:116–124

    Article  PubMed  Google Scholar 

  71. Blank M, Shoenfeld Y (2010) Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome. Clin rev allergy immunol 38:141–147

    Article  PubMed  CAS  Google Scholar 

  72. Erkan D, Espinosa G, Cervera R (2010) Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun Rev 10:74–79

    Article  PubMed  Google Scholar 

  73. Pittschieler S, Wiedermann FJ (2011) Catastrophic antiphospholipid syndrome associated with methicillin-resistant Staphylococcus aureus infection. Autoimmun Rev 10:238

    Article  PubMed  Google Scholar 

  74. Ideguchi H, Ohno S, Uehara T and Ishigatsubo Y (2011) Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital. Clin Rev Allergy Immunol. doi:10.1007/s12016-011-8269-8

  75. Lambrianides A, Carroll CJ, Pierangeli SS et al (2010) Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways. J Immunol 184:6622–6628

    Article  PubMed  CAS  Google Scholar 

  76. Graham A, Ford I, Morrison R, Barker RN, Greaves M, Erwig LP (2009) Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome. J Immunol 182:1756–1762

    PubMed  CAS  Google Scholar 

  77. Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y (2006) Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology 45(Suppl 4):iv8–iv13

    Article  PubMed  Google Scholar 

  78. Atzeni F, Turiel M, Hollan I et al (2010) Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases. Autoimmun Rev 9:845–848

    Article  PubMed  CAS  Google Scholar 

  79. Sitia S, Tomasoni L, Atzeni F et al (2010) From endothelial dysfunction to atherosclerosis. Autoimmun Rev 9:830–834

    Article  PubMed  CAS  Google Scholar 

  80. Turiel M, Sitia S, Atzeni F et al (2010) The heart in rheumatoid arthritis. Autoimmun Rev 9:414–418

    Article  PubMed  CAS  Google Scholar 

  81. Ruiz-Irastorza G, Khamashta MA (2009) Managing lupus patients during pregnancy. Best practice & research. Clin Rheumatol 23:575–582

    Google Scholar 

  82. Paran D, Fireman E, Levartovsky D et al (2007) Pulmonary dysfunction in systemic lupus erythematosus and anti-phospholipid syndrome patients. Scand J Rheumatol 36:285–290

    Article  PubMed  CAS  Google Scholar 

  83. Zeki AA, Schivo M, Chan AL et al (2010) Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun 34:J327–J338

    Article  PubMed  CAS  Google Scholar 

  84. Chandran V, Raychaudhuri SP (2010) Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 34:J314–J321

    Article  PubMed  CAS  Google Scholar 

  85. Invernizzi P (2010) Geoepidemiology of autoimmune liver diseases. J Autoimmun 34:J300–J306

    Article  PubMed  CAS  Google Scholar 

  86. Shapira Y, Agmon-Levin N, Shoenfeld Y (2010) Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 34:J168–J177

    Article  PubMed  CAS  Google Scholar 

  87. Youinou P, Pers JO, Gershwin ME, Shoenfeld Y (2010) Geo-epidemiology and autoimmunity. J Autoimmun 34:J163–J167

    Article  PubMed  CAS  Google Scholar 

  88. Arnson Y, Shoenfeld Y, Amital H (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34:J258–J265

    Article  PubMed  CAS  Google Scholar 

  89. Anzilotti C, Pratesi F, Tommasi C, Migliorini P (2010) Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmun Rev 9:158–160

    Article  PubMed  CAS  Google Scholar 

  90. Szodoray P, Szabo Z, Kapitany A et al (2010) Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev 9:140–143

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, 52621, Tel-Hashomer, Israel

    Nancy Agmon-Levin

  2. Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

    Nancy Agmon-Levin

  3. Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA

    Carlo Selmi

  4. Clinical Immunology, Humanitas Clinical and Research Center, via A. Manzoni 113, 20089, Rozzano, Milan, Italy

    Carlo Selmi

Authors
  1. Nancy Agmon-Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlo Selmi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carlo Selmi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agmon-Levin, N., Selmi, C. The Autoimmune Side of Heart and Lung Diseases. Clinic Rev Allerg Immunol 44, 1–5 (2013). https://doi.org/10.1007/s12016-012-8335-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-012-8335-x

Keywords

Search

Navigation